Table 1 Baseline demographics, overall and per treatment arm
|  | All patients (n = 36) Mean (SD) / Median [range]/ n (%) | Cinacalcet (n = 15) Mean (SD) / Median [range] / n (%) | Control (n = 21) Mean (SD) / Median [range]/ n (%) | p-Value |
|---|---|---|---|---|
Demographics | ||||
 Age | 51 (15) | 45 (16) | 54 (13) | 0.068 |
 Male | 23 (64%) | 11 (73%) | 12 (57%) | 0.319 |
 Caucasian | 30 (83%) | 14 (93%) | 16 (76%) | 0.174 |
 Diabetes | 4 (11%) | 1 (7%) | 3 (14%) | 0.473 |
 Smoking | 9 (25%) | 5 (33%) | 4 (19%) | 0.329 |
 Height (cm) | 166 (11) | 169 (11) | 163 (11) | 0.298 |
 Weight (kg) | 73 (15) | 74 (15) | 72 (15) | 0.626 |
 BMI | 26 (5) | 25 (5) | 26 (5) | 0.927 |
Cardiovascular | ||||
 SBP (mmHg) | 131 (26) | 133 (27) | 130 (26) | 0.789 |
 DBP (mmHg) | 72 (13) | 72 (13) | 72 (13) | 0.877 |
 MI | 5 (14%) | 2 (13%) | 3 (14%) | 0.935 |
 Angina | 7 (19%) | 5 (33%) | 2 (10%) | 0.075 |
 Stroke | 3 (8%) | 0 | 3 (14%) | 0.126 |
 TIA | 7 (19%) | 2 (13%) | 5 (24%) | 0.433 |
 All CVD | 14 (39%) | 6 (40%) | 8 (38%) | 0.908 |
 NYHA score | 1: 26 (72%) | 1: 10 (67%) | 1: 16 (76%) | 0.529 |
2–3:10 (28%) | 2–3:5 (33%) | 2–3:5 (24%) |  | |
 CCS score | 0:33 (92%) | 0: 14 (93%) | 0: 19 (91%) | 0.759 |
1–3: 3 (8%) | 1–3: 1 (7%) | 1–3: 2 (9%) |  | |
Renal history | ||||
 Adequate dialysis | 23 (80%) | 8 (73%) | 15 (83%) | 0.265 |
 Dialysis duration (m) | 38 [6–319] | 33 [6–319] | 43 [10–222] | 0.072 |
 Previous transplant | 9 (25%) | 4 (27%) | 5 (24%) | 0.845 |
Hyperparathyroidism medication at baseline | ||||
 Calcium binder | 15 (42%) | 7 (47%) | 8 (38%) | 0.607 |
 Non-calcium binder | 30 (83%) | 13 (87%) | 17 (81%) | 0.650 |
 VDRA | 35 (97%) | 15 (100%) | 20 (95%) | 1.000 |